M5049

· EMD Serono Research & Development Institute, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for M5049, covering 2022-06-06 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE) [Phase 2]